Company Valuation: HOB Biotech Group Corp.,Ltd

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025
Market Cap 1 3,973 2,114 2,192 5,946 9,640
Change - -46.79% 3.7% 171.25% 62.14%
Enterprise Value (EV) 1 3,549 1,890 2,084 5,940 9,624
Change - -46.74% 10.27% 184.97% 62.03%
P/E 45x 50.8x 47x 165x 416x
PBR 5.16x 2.71x 2.7x 7.32x 11.8x
PEG 2.7x -1x 3.9x -7.6x -11.5x
Capitalization / Revenue 12.5x 6.6x 5.56x 14.8x 24.2x
EV / Revenue 11.2x 5.9x 5.28x 14.8x 24.2x
EV / EBITDA 34.2x 27.4x 24.1x 71.3x 120x
EV / EBIT 42.1x 45x 38.7x 134x 545x
EV / FCF -40.4x -13.6x -14.7x -122x -234x
FCF Yield -2.47% -7.33% -6.79% -0.82% -0.43%
Dividend per Share 2 0.53 0.3 0.4 0.3 0.2
Rate of return 0.84% 0.89% 1.15% 0.31% 0.13%
EPS 2 1.4 0.66 0.74 0.58 0.37
Distribution rate 37.9% 45.5% 54.1% 51.7% 54.1%
Net sales 1 317.7 320.4 394.4 402.3 398.4
EBITDA 1 103.9 68.95 86.55 83.31 80.36
EBIT 1 84.33 42.01 53.85 44.16 17.67
Net income 1 86.19 41.65 47.33 36.8 23.2
Net Debt 1 -424 -223.6 -107.6 -5.932 -15.95
Reference price 2 63.00 33.52 34.76 95.50 153.80
Nbr of stocks (in thousands) 63,058 63,058 63,058 62,257 62,678
Announcement Date 24/04/22 25/04/23 25/04/24 17/03/25 17/03/26
1CNY in Million2CNY
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 846M
-54.61x16.38x-119.67x-.--% 21B
17.02x1.93x8.04x1.51% 9.53B
24.54x4.5x12.69x - 6.86B
-51.29x7.85x-65.88x-.--% 5.3B
18.99x6.51x14.72x3.03% 5.12B
168.46x4.38x28.46x-.--% 4.82B
20.24x3.55x11.05x1.88% 4.2B
15.66x - - 4.09% 2.63B
Average 19.88x 6.44x -15.80x 1.5% 6.7B
Weighted average by Cap. -0.88x 8.87x -42.93x 0.92%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 688656 Stock
  4. Valuation HOB Biotech Group Corp.,Ltd